Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1

Journal of General Virology

Volumn 77, Issue 4, 1996, Pages 753-758

  Schønning, Kristian ^a   Jansson, Britt ^b   Olofsson, Sigvard ^b   Hansen, John Erik Stig ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; MONOCLONAL ANTIBODY; MUTANT PROTEIN; OLIGOSACCHARIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VIRUS NEUTRALIZATION;

EID: 0029940696     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-4-753     Document Type: Article

References (29)

1. AKERBLOM, L., HINKULA, J., BROLIDEN, P.-A., MÄKITALO, B., FRIDBERGER, T., ROSEN, J., VILLACRES-ERIKSSON, M., WOREIN, B. & WAHREN, B. (1990). Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS 4, 953-960.
2. ALEXANDER, S. & ELDER, J. H. (1984). Carbohydrate dramatically influences reactivity to viral glycoprotein antigens. Science 226, 1328-1330.
3. ARENDRUP, M., SONNERBORG, A., SVENNERHOLM, B., ÅKERBLOM, L., NIELSES, C., CLAUSES, H., OLOFSSON, S , NIELSEN, J. O. & HANSEN, J.-E. S. (1993). Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. Journal of General Virology 74, 855-863.
4. BACK, N. K. T., SMIT, L., DE JONG, J.-J., KEULEN, W., SCHUTTEN, M., GOUDSMIT, J. & TERSMETTE, M. (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
5. BALFE, P., SIMMONDS, P., LUDLAM, C. A., BISHOP, J. O. & LEIGH BROWN, A. J. (1990). Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source : rate of sequence change and low frequency of inactivating mutations. Journal of Virology 64, 6221-6233.
6. BOSCH, M. L., ANDEWEG, A. C., SCHIPPER, R. & KENTER, M. (1994). Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. Journal of Virology 68, 7566-7569.
7. BOU-HABIB, D. C., RODERIQUEZ, G., ORAVECZ, T., BERMAN, P. W., LUSSO, P. & NORCROSS, M. A. (1994). Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. Journal of Virology 68, 6006-6013.
8. CAUST. J., DYALL-SMITH, M. L., LAZDINS, I. & HOLMES, I. H. (1987). Glycosylation, an important modifier of rotavirus antigenicity. Archives of Virology 96, 123-134.
9. CHAMAT, S., NARA, P., BERQUIST, L., WHALLEY, A., MORROW, W. J. W., KÖHLER, H. & KANG, C.-Y. (1992). Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Journal of Immunology 149, 649-654.
10. COFFIN, J. M. (1990). Retroviridae and their replication. In Virology, 2nd edn, pp. 1437-1500. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press
11. GOUDSMIT, J., DEBOUCK, C., MELOEN, R H., SMIT, L., BAKKER, M., ASHER, D. M., WOLFF, A. V., GIBBS, C. J., JR & GAJDUSEK, D. C. (1988). Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proceedings of the National Academy of Sciences, USA 85, 4478-4482.
12. GRAM, G. J., HEMMING, A., BOLMSTEDT, A., JANSSON, B., AKERBLOM, L., NIELSEN, J. O. & HANSEN, J.-E. S. (1994). Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4. Archives of Virology 139, 253-261.
13. HAHN, B. H., SHAW, G. M., TAYLOR, M. E., REDFIELD, R. D., MARKHAM, P. D., SALAHUDDIN, S. Z., WONG-STAAL, F., GALLO, R. C., PARKS. E. S & PARKS, W. P. (1986). Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk of AIDS. Science 232, 1548-1553.
14. HANSEN, J.-E. S., JANSSOS, B., GRAM, G. J., CLAUSEN, H., NIELSEN, J. O. & OLOFSSON, S. (1996). Sensitivity to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop. Archives of Virology (in press).
15. HARADA, S., KOYANAGI, Y. & YAMAMATO, N. (1985). Infection of HTLV-III/LAV in HTLV-I-carrying MT-2 and MT-4 cells and application in a plaque assay. Science 229, 563-566.
16. JAVAHERIAN, K., LANGLOIS, A. J., MCDANAL, C., ROSS, K. L., ECKLER, L. I., JELLIS, C. L., PROFY, A. T., RUSCHE, J. R., BOLOGNESI, D. P., PUTNEY, S. D. & MATTHEWS, T. J. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proceedings of the National Academy of Sciences, USA 86, 6768-6772.
17. LAROSA, G. J., DAVIDE, J. P., WEINHOLD, K., WATERBURY, J. A., PROFY, A T., LEWIS, J A., LANGLOIS, A. J., DREESMAN, G. R., BOSWELL, R. N., SHADDUCK, P., HOLLEY, L. H., KARPLUS, M., BOLOGNESI, D. P., MATTHEWS, T. J., EMINI, E. A. & PUTNEY, S. D. (1990). Conserved sequence and structural elements m the HIV-principal neutralizing determinant. Science 249, 932-935.
18. MCKEATING, J. A., MCKNIGHT, A., MCINTOSH, K., CLAPHAM, P R., MULDER, C. & WEISS, R. A. (1989). Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. Journal of General Virology 70, 3327-3333.
19. MASUDA, T., MATSUSHITA, S., KURODA, M. J., KANNAGI, M., TAKATSUKI, K. & HARADA, S. (1990). Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region. Journal of Immunology 145, 3240-3246.
20. MYERS, G. & LENROOT, R. (1992). HIV glycosylation: what does it portend? AIDS Research and Human Retroviruses 8, 1459-1460
21. NIELSEN, C. M., BYGBJERG, I. C & VESTERGAARD, B. F. (1987). Detection of HIV antigens in eluates of whole blood collected on filter paper [leuer]. Lancet i, 566-567.
22. OVERBAUGH, J. & RUDENSEY, L. M (1992). Alterations in potential sites for glycosylation predominate evolution of the simian immunodeficiency virus envelope gene in macaques. Journal of Virology 66, 5937-5948.
23. POPOVIC, M., SARNAGADHARAN, M. G., READ, E. & GALLO, R. C. (1984). Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500.
24. PROFY, A. T., SALINAS, P. A., ECKLER, L. I., DUNLOP, N. M., NARA, P. L. & PUTNEY, S. D. (1990). Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. Journal of Immunology 144, 4641-4647.
25. REED, L. J. & MUENCH, H. (1938). A simple method for estimating 50% endpoint. American Journal of Hygiene 21, 493-497.
26. RUSCHE, J. R., JAVAHERIAN, K., MCDANAL, C., PETRO, J , LYNN, D. L., GRIMILIA, R., LANGLOIS, R., GALLO, R. C., ARTHUR, L. O., FISCHINGER, P. J., BOLOGNESI, D. P., PUTNEY, S. D. & MATTHEWS, T. J. (1988). Antibodies that inhibit fusion of human immunodeficiency virus infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proceedings of the National Academy of Sciences, USA 85, 3198-3202.
27. SALAHUDDIN, S., MARKHAM, P., WONG-STAAL, F., FRANCHINI, G., KALYANARAMAN, V. & GALLO, R. C. (1983). Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord lymphocytes. Virology 129, 51-64.
28. SKEHEL, J. J., STEVENS, D. J., DANIELS, R. S., DOUGLAS, A. R., KNOSSOW, M , WILSON, I. A. & WILEY, D. C. (1984). A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proceedings of the National Academy of Sciences, USA 81, 1779-1783.
29. WOLFS, T. F. W., DE JONG, J.-J., VAN DEN BERG, H., TUNAGEL, J. M. G. H., KRONE, W. J. A. & GOUDSMIT, J. (1990). Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proceedings of the National Academy of Sciences, USA 87, 9938-9942.